Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Interest Income Expense
Vivos Therapeutics Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Interest Income Expense
-$369.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Interest Income Expense
-$151m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-1%
|
|
CVS Health Corp
NYSE:CVS
|
Interest Income Expense
-$2.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-18%
|
|
Cigna Corp
NYSE:CI
|
Interest Income Expense
-$3.3B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Interest Income Expense
-$187.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-9%
|